Natco Pharma, Glenmark Pharmaceuticals, and IPCA Laboratories Ltd. Strong Q3 earnings, an optimistic outlook, and recent news developments all contributed to the sector's positive sentiment.
The Natco Pharma share price rose over 18% to touch a 52-week high following the firm revealed that it raised its guidance for profit after tax to above ₹1,200 crore from ₹1,000-1,200 crore before, in a post-earnings conference call on Thursday, as per report. Also Read: M&M share price jumps over 5% to record high on supply deal with Volkswagen "Exciting news! Mint is now on WhatsApp Channels
. Read more on livemint.com